-
August 3, 2010
Based on our Pharmacor advisory service entitled Obesity, Decision Resources is offering an exclusive analyst call entitled Who Will Be the Winners and Losers in the Obesity Wars? Fallout from the FDA Advisory Committee’s Vote on Qnexa. Because this presentation will feature major updates, it is ONLY available to purchasers of this Pharmacor advisory service.
This analyst call will be held on August 3, 2010. Contact us to learn how you can purchase this service and attend the analyst call.
Click here to view the invite.
Read More
-
July 29, 2010
Based on our Pharmacor advisory service entitled Breast Cancer, Decision Resources is offering an exclusive analyst call entitled A Crushing Blow for Avastin? Assessing the Impact of an FDA Panel’s 12 to 1 Vote to Withdraw Avastin’s Marketing Approval for Breast Cancer. Because this presentation will feature major updates, it is ONLY available to purchasers of this Pharmacor advisory service.
This analyst call will be held on July 29, 2010. Contact us to learn how you can purchase this service and attend the analyst call.
Click here to view the invite.
Read More
-
July 27, 2010
As part of our Biosimilars Advisory Service, Decision Resources is offering an exclusive analyst call entitled Payer Perspectives of Biosimilars: Priorities, Barriers to Entry and Opportunities. This analyst call is open ONLY to subscribers of Decision Resources’ Biosimilars Advisory Service.
This analyst call was held on July 27, 2010. Contact us to learn how you can purchase this service and access a recorded playback of this event.
Click here to view the invite.
Read More
-
July 26, 2010
Based on our Pharmacor Venous Thromboembolism advisory service, Decision Resources is offering an exclusive analyst call entitled Venous Thromboembolism: How Will Sanofi-Aventis’s Semuloparin (AVE-5026) Compete in a Market That Will Soon Feature a Range of Oral Anticoagulants? Because this presentation features major updates, it is ONLY available to purchasers of this Pharmacor advisory service.
This analyst call was held on July 26, 2010. Contact us to learn how you can purchase this service and access a recorded playback of this event.
Click here to view the invite.
Read More
-
July 15, 2010
Based on our Pharmacor Type 2 Diabetes advisory service, Decision Resources is offering an exclusive analyst call entitled How Will Key Agents in Development Impact the Type 2 Diabetes Market? News from the ADA’s 70th Annual Scientific Sessions. Because this presentation features major updates, it is ONLY available to purchasers of this Pharmacor advisory service.
This analyst call was held on July 15, 2010. Contact us to learn how you can purchase this service and access a recorded playback of this event.
Click here to view the invite.
Read More
-
July 13, 2010
Based on our Pharmacor Renal Cell Carcinoma advisory service, Decision Resources is offering an exclusive analyst call entitled Renal Cell Carcinoma: Will the Current Market Leader, Pfizer’s Sutent, be Challenged by the Changing Dynamics in this Crowded Market? Because this presentation features major updates, it is ONLY available to purchasers of this Pharmacor advisory service.
This analyst call was held on July 13, 2010. Contact us to learn how you can purchase this service and access a recorded playback of this event.
Click here to view the invite.
Read More
-
July 8, 2010
Based on our Pharmacor Prostate Cancer advisory service, Decision Resources is offering an exclusive analyst call entitled Rising Out of the Crowded Prostate Cancer Pipeline: Which New and Emerging Agents Will Become Market Leaders in 2019? Because this presentation features major updates, it is ONLY available to purchasers of this Pharmacor advisory service.
This analyst call was held on July 8, 2010. Contact us to learn how you can purchase this service and aaccess a recorded playback of this event.
Click here to view the invite.
Read More
-
July 7, 2010
As part of our Biosimilars Advisory Service, Decision Resources is offering an exclusive analyst call entitled Substitution and Interchangeability: Physician Perspectives and Market Impact. This analyst call is open ONLY to subscribers of Decision Resources’ Biosimilars Advisory Service.
This analyst call was held on July 7, 2010. Contact us to learn how you can purchase this service and access a recorded playback of this event.
Click here to view the invite.
Read More
-
June 28, 2010
Based on our Pharmacor advisory service entitled Gastric Cancer, Decision Resources is offering an exclusive analyst call entitled What Impact Will the Emergence of Herceptin and Other Targeted Therapies Have on the Gastric Cancer Drug Market? News from ASCO. Because this presentation features major updates, it is ONLY available to purchasers of this Pharmacor advisory service.
This analyst call was held on June 28, 2010. Contact us to learn how you can purchase this Pharmacor advisory service and access a recorded playback of this event.
Click here to view the invite.
Read More
-
June 25, 2010
Based on our Pharmacor advisory service entitled Multiple Myeloma, Decision Resources is offering an exclusive analyst call entitled Revlimid Continues to Show Promise as a Maintenance Treatment in Multiple Myeloma – News from ASCO. Because this presentation features major updates, it is ONLY available to purchasers of this Pharmacor advisory service.
This analyst call was held on June 25, 2010. Contact us to learn how you can purchase this Pharmacor advisory service and access a recorded playback of this event.
Click here to view the invite.
Read More
-
June 24, 2010
Based on our Pharmacor advisory service entitled Ovarian Cancer, Decision Resources is offering an exclusive analyst call entitled Avastin and Other Key Emerging Agents Are Poised to Change the Landscape of Ovarian Cancer Treatment – News from ASCO. Because this presentation features major updates, it is ONLY available to purchasers of this Pharmacor advisory service.
This analyst call was held on June 24, 2010. Contact us to learn how you can purchase this Pharmacor advisory service and access a recorded playback of this event.
Click here to view the invite.
Read More
-
June 17, 2010
Based on our Pharmacor advisory service entitled Osteoporosis, Decision Resources is offering an exclusive analyst call entitled Prolia is Approved for the Treatment of Postmenopausal Osteoporosis: How Will It Compete in This Mature, Crowded Market? Because this presentation features major updates, it is ONLY available to purchasers of this Pharmacor advisory service.
This analyst call was held on June 17, 2010. Contact us to learn how you can purchase this Pharmacor advisory service and access a recorded playback of this event.
Click here to view the invite.
Read More
-
June 15, 2010
Based on our Pharmacor advisory service entitled Psoriasis, Decision Resources is offering an exclusive analyst call entitled Psoriasis: The Uptake of Stelara in the United States: How are Physicians Integrating this IL-12/23 Inhibitor into a Market Dominated by TNF-alpha Inhibitors? Because this presentation features major updates, it is ONLY available to purchasers of this Pharmacor advisory service.
This analyst call was held on June 15, 2010. Contact us to learn how you can purchase this Pharmacor advisory service and access a recorded playback of this event.
Click here to view the invite.
Read More
-
June 11, 2010
Based on our Pharmacor advisory service entitled Hepatitis C Virus, Decision Resources is offering an exclusive analyst call entitled Hepatitis C Virus: ADVANCE Clinical Trial Data Provides New Details Regarding Telaprevir’s Clinical Profile. Because this presentation features major updates, it is ONLY available to purchasers of this Pharmacor advisory service.
This analyst call was held on June 11, 2010. Contact us to learn how you can purchase this Pharmacor advisory service and access a recorded playback of this event.
Click here to view the invite.
Read More
-
June 10, 2010
Based on our Pharmacor advisory service entitled Hypertension, Decision Resources is offering an exclusive analyst call entitled Hypertension: Does Novartis’s Tekturna Still Have What it Takes to Meet Expectations? Because this presentation features major updates, it is ONLY available to purchasers of this Pharmacor advisory service.
This analyst call was held on June 10, 2010. Contact us to learn how you can purchase this Pharmacor advisory service and access a recorded playback of this event.
Click here to view the invite.
Read More